O180 SAFETY AND IMMUNOGENICITY OF THE HPV-16/18 AS04-ADJUVANTED VACCINEIN HIV-POSITIVE WOMEN IN SOUTH AFRICA UP TO 12 MONTHS AFTER VACCINATION |
Denny, L.;Hendricks, B.;Gordon, C.;Herve, C.;Thomas, F.;Hezareh, M.;Dobbelaere, K.;Durand, C.;Struyf, F.; |
International Journal of Gynecology & Obstetrics |
2012-10-01 |
查看 |